Quiet on the insider front: nobody at MSP Recovery, Inc. bought or sold MSPR shares in open-market trades this past year.
On the institutional side, 1 funds reported holding MSPR at the end of Q2 2026, and funds were split between buying and selling. Zooming out by quarter: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 6, 2024 | Palantir Technologies Inc. | Other | Sell | 111,760 | $0.10 | $11K | SEC |
| Nov 6, 2024 | Palantir Technologies Inc. | Other | Sell | 340,300 | $0.11 | $37K | SEC |
| Nov 6, 2024 | Palantir Technologies Inc. | Other | Sell | 506,296 | $0.13 | $66K | SEC |
| Nov 1, 2024 | Palantir Technologies Inc. | 10% Owner | Sell | 55,921 | $0.12 | $7K | SEC |
| Nov 1, 2024 | Palantir Technologies Inc. | 10% Owner | Sell | 381,487 | $0.11 | $42K | SEC |
| Nov 1, 2024 | Palantir Technologies Inc. | 10% Owner | Sell | 337,174 | $0.11 | $37K | SEC |
| Aug 28, 2024 | Ruiz John Hasan | CEO | Buy | 50,000 | $0.24 | $12K | SEC |
| Aug 22, 2024 | Ruiz John Hasan | CEO | Buy | 360,620 | $0.28 | $101K | SEC |
| Aug 21, 2024 | Ruiz John Hasan | CEO | Buy | 100,000 | $0.28 | $28K | SEC |
| Aug 20, 2024 | Ruiz John Hasan | CEO | Buy | 100,000 | $0.25 | $25K | SEC |
| Aug 19, 2024 | Ruiz John Hasan | CEO | Buy | 100,000 | $0.25 | $25K | SEC |
| Aug 16, 2024 | Ruiz John Hasan | CEO | Buy | 168,000 | $0.25 | $42K | SEC |
| Apr 3, 2024 | Cano Health, Inc. | 10% Owner | Sell | 1,109,500 | $0.88 | $976K | SEC |
| Apr 3, 2024 | Cano Health, Inc. | 10% Owner | Sell | 30,376 | $0.67 | $20K | SEC |
| Mar 29, 2024 | Cano Health, Inc. | 10% Owner | Sell | 25,778 | $0.69 | $18K | SEC |
There were no open-market insider trades in MSPR in the last 12 months. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
1 investment managers reported holding MSPR in SEC Form 13F filings for Q2 2026.
No congressional trades in MSPR were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).